These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 9543062

  • 1. Relative importance of CD4+ and CD8+ T cell repertoires in the development of acute graft-versus-host disease in a murine model of bone marrow transplantation.
    Miconnet I, de La Selle V, Bruley-Rosset M.
    Bone Marrow Transplant; 1998 Mar; 21(6):583-90. PubMed ID: 9543062
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Specific donor Vbeta-associated CD4 T-cell responses correlate with severe acute graft-versus-host disease directed to multiple minor histocompatibility antigens.
    Jones SC, Friedman TM, Murphy GF, Korngold R.
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):91-105. PubMed ID: 14750075
    [Abstract] [Full Text] [Related]

  • 4. Vbeta spectratype analysis reveals heterogeneity of CD4+ T-cell responses to minor histocompatibility antigens involved in graft-versus-host disease: correlations with epithelial tissue infiltrate.
    Friedman TM, Statton D, Jones SC, Berger MA, Murphy GF, Korngold R.
    Biol Blood Marrow Transplant; 2001 Feb; 7(1):2-13. PubMed ID: 11215694
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. T cell subsets involved in lethal graft-versus-host disease directed to immunodominant minor histocompatibility antigens.
    Berger M, Wettstein PJ, Korngold R.
    Transplantation; 1994 Apr 15; 57(7):1095-102. PubMed ID: 7909395
    [Abstract] [Full Text] [Related]

  • 7. Immunodominant CD4+ T cell receptor Vbeta repertoires involved in graft-versus-host disease responses to minor histocompatibility antigens.
    Berger MA, Korngold R.
    J Immunol; 1997 Jul 01; 159(1):77-85. PubMed ID: 9200441
    [Abstract] [Full Text] [Related]

  • 8. Lethal graft-versus-host disease in mice directed to multiple minor histocompatibility antigens: features of CD8+ and CD4+ T cell responses.
    Korngold R.
    Bone Marrow Transplant; 1992 May 01; 9(5):355-64. PubMed ID: 1352163
    [Abstract] [Full Text] [Related]

  • 9. A CD8 DE loop peptide analog prevents graft-versus-host disease in a multiple minor histocompatibility antigen-mismatched bone marrow transplantation model.
    Choksi S, Kim JC, Whitaker-Menezes D, Murphy GF, Friedman TM, Korngold R.
    Biol Blood Marrow Transplant; 2004 Oct 01; 10(10):669-80. PubMed ID: 15389433
    [Abstract] [Full Text] [Related]

  • 10. Peripheral tolerance to host minor histocompatibility antigens in radiation bone marrow chimeras abrogates lethal GVHD while preserving GVL effect.
    de la Selle V, Miconnet I, Gilbert D, Bruley-Rosset M.
    Bone Marrow Transplant; 1995 Jul 01; 16(1):111-8. PubMed ID: 7581109
    [Abstract] [Full Text] [Related]

  • 11. Oligoclonal expansion of T cell receptor V beta 2 and 3 cells in the livers of mice with graft-versus-host disease.
    Chen W, Howell CD.
    Hepatology; 2002 Jan 01; 35(1):23-9. PubMed ID: 11786956
    [Abstract] [Full Text] [Related]

  • 12. Biased liver T cell receptor V beta repertoire in a murine graft-versus-host disease model.
    Howell CD, Li J, Roper E, Kotzin BL.
    J Immunol; 1995 Sep 01; 155(5):2350-8. PubMed ID: 7650370
    [Abstract] [Full Text] [Related]

  • 13. Repertoire analysis of CD8+ T cell responses to minor histocompatibility antigens involved in graft-versus-host disease.
    Friedman TM, Gilbert M, Briggs C, Korngold R.
    J Immunol; 1998 Jul 01; 161(1):41-8. PubMed ID: 9647205
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. PD-1-PD-L1 pathway is involved in suppressing alloreactivity of heart infiltrating t cells during murine gvhd across minor histocompatibility antigen barriers.
    Schilbach K, Schick J, Wehrmann M, Wollny G, Simon P, Schlegel PG, Eyrich M.
    Transplantation; 2007 Jul 27; 84(2):214-22. PubMed ID: 17667813
    [Abstract] [Full Text] [Related]

  • 16. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR, Majewski D, Ozker K, Hanson G.
    J Immunol; 1998 Sep 01; 161(5):2610-9. PubMed ID: 9725263
    [Abstract] [Full Text] [Related]

  • 17. Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras.
    Brochu S, Baron C, Hétu F, Roy DC, Perreault C.
    J Immunol; 1995 Dec 01; 155(11):5104-14. PubMed ID: 7594519
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD, Becker EE, LaBelle JL, Truitt RL.
    J Immunol; 1999 Dec 15; 163(12):6479-87. PubMed ID: 10586039
    [Abstract] [Full Text] [Related]

  • 20. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
    Li JM, Waller EK.
    Biol Blood Marrow Transplant; 2004 Aug 15; 10(8):540-51. PubMed ID: 15282532
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.